Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells

被引:53
作者
Tourneur, L
Mistou, S
Michiels, FM
Devauchelle, V
Renia, L
Feunteun, J
Chiocchia, G
机构
[1] Univ Paris 05, Inst Cochin, Dept Immunol, IFR 116,CNRS,UMR 8104,INSERM,U567, F-75014 Paris, France
[2] Inst Gustave Roussy, Oncol Mol Lab, CNRS, Unite Rech Associee 1158, F-94805 Villejuif, France
关键词
FADD; Fas ligand; thyroid; tumor;
D O I
10.1038/sj.onc.1206399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Downregulation of proapoptotic molecules like Fas or caspase 8, or upregulation of antiapoptotic molecules like FLICE inhibitory protein has been suggested to be a regulatory mechanism set up by tumor cells to block the death signal received via death receptors. In an in-depth study of the Fas/FasL-signaling pathway in thyroid tumor development, we have demonstrated that tumor cells specifically downregulate the multideath receptor adapter Fas-associated death domain (FADD). The regulation of FADD expression occurred only at the protein level. Furthermore, in the absence of FADD, Fas-signaling resulted in accelerated growth of thyrocytes. Since thyrocytes also acquired FasL expression during tumor development, the absence of FADD protein could lead to greater resistance to numerous death receptor-mediated apoptosis, stimulation of their own proliferation through Fas/FasL interaction, and the capacity to counter-attack the infiltrating lymphocytes.
引用
收藏
页码:2795 / 2804
页数:10
相关论文
共 46 条
[1]   Editorial: Dying (apoptosing?) for a consensus on the fas death pathway in the thyroid [J].
Baker, JR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) :2593-2595
[2]   Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis [J].
Batteux, F ;
Lores, P ;
Bucchini, D ;
Chiocchia, G .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1681-1688
[3]  
Bernstein J, 1997, J BIOL CHEM, V272, P9356
[4]   TRAIL death pathway expression and induction in thyroid follicular cells [J].
Bretz, JD ;
Rymaszewski, M ;
Arscott, PL ;
Myc, A ;
Ain, KB ;
Thompson, NW ;
Baker, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23627-23632
[5]   Activation of apoptosis signal regulating kinase 1 (ASK1) by the adapter protein Daxx [J].
Chang, HY ;
Nishitoh, H ;
Yang, XL ;
Ichijo, H ;
Baltimore, D .
SCIENCE, 1998, 281 (5384) :1860-1863
[6]   Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells [J].
Clemens, MJ ;
Bushell, M ;
Jeffrey, IW ;
Pain, VM ;
Morley, SJ .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (07) :603-615
[7]   Fas engagement accelerates liver regeneration after partial hepatectomy [J].
Desbarats, J ;
Newell, MK .
NATURE MEDICINE, 2000, 6 (08) :920-923
[8]   Dichotomy between naive and memory CD4+ T cell responses to Fas engagement [J].
Desbarats, J ;
Wade, T ;
Wade, WF ;
Newell, MK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) :8104-8109
[9]   The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors [J].
Djerbi, M ;
Screpanti, V ;
Catrina, AI ;
Bogen, B ;
Biberfeld, P ;
Grandien, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :1025-1031
[10]   Modulation of apoptosis by procaspase-2 short isoform:: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization [J].
Droin, N ;
Rébé, C ;
Bichat, F ;
Hammann, A ;
Bertrand, R ;
Solary, E .
ONCOGENE, 2001, 20 (02) :260-269